WHO ICTRP trial
A clinical trial to see the efficacy of angamardaprashamana ghanavati in…
CTRI/2021/02/031222 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2021/02/031222 |
|---|---|
| Public title | A clinical trial to see the efficacy of angamardaprashamana ghanavati in patients with chronic fatigue syndrome and repetitive stress injury |
| Scientific title | A conceptual and applied study on angamardaprashamana mahakashaya vis-a-vis chronic fatigue syndrome and repetitive stress injury |
| Primary sponsor | Dr Kavya K |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | India |
| Conditions | Health Condition 1: PCS- |
| Interventions | Intervention1: ANGAMARDAPRASHAMANA GANAVATI: â?¢Drug: Angamardaprashmana dashemani dravyas of Charaka samhita; viz Vidariganda, Prishnaparni, Brihati, Kantakarika, Eranda, Kakoli, Chandana, Ushira, Ela & Madhuka; all drugs taken in equal… |
| Registration date | Nov 2, 2021 |
| Target size | 40 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: